Governance of the clinical pathway and management of the patient suffering from epilepsy and drug-resistant epilepsy
Open Access
- 28 June 2022
- journal article
- review article
- Published by Aboutscience Srl in Global and Regional Health Technology Assessment
- Vol. 9 (Suppl. 2), 4-9
- https://doi.org/10.33393/grhta.2022.2418
Abstract
Epilepsy is a diffuse chronic neurological disease affecting around 50 million people worldwide. The diagnostic criteria by the International League against Epilepsy must be fulfilled to diagnose the disease, which is characterized by brief and transient episodes of abnormal neuronal activity involving one or both hemispheres, depending on the epilepsy type. The diagnosis of epilepsy should be properly and timely made because patients suffering from the disease are affected not only by seizure recurrence but also by epilepsy-related psychiatric and/or cognitive comorbidities that may have a huge impact with severe professional and social implications. It is of vital importance to define a specific governance model that has to be virtuously applied into the different phases of the clinical pathway of the patients with epilepsy in order to guarantee them the best model of care possible.Keywords
This publication has 35 references indexed in Scilit:
- Prevalence and etiology of epilepsy in a Norwegian county—A population based studyEpilepsia, 2015
- ILAE Official Report: A practical clinical definition of epilepsyEpilepsia, 2014
- Precision medicine: an approach to R&D for delivering superior medicines to patientsClinical and Translational Medicine, 2012
- Epilepsy in the elderly: facts and challengesActa Neurologica Scandinavica, 2010
- Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic StrategiesEpilepsia, 2010
- Recommendation for a definition of acute symptomatic seizureEpilepsia, 2010
- Accidents and injuries in patients with epilepsyExpert Review of Neurotherapeutics, 2009
- Intractable epilepsy: management and therapeutic alternativesThe Lancet Neurology, 2008
- The epidemiology of epilepsy in Europe – a systematic reviewEuropean Journal of Neurology, 2005
- Early Identification of Refractory EpilepsyThe New England Journal of Medicine, 2000